Asthma trials recruiting in Illinois

All Asthma trials nationally

Cities in Illinois

Recruiting trials in Illinois

• A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
  NCT07532265 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Illinois: Chicago
• A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
  NCT06664619 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · Illinois: Westchester
• A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice
  NCT07556159 · Phase: Not specified · Ages: 6 Years and older · Sex: All (male and female) · Illinois: Chicago
• A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
  NCT05757102 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · Illinois: Normal
• A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
  NCT07219173 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Illinois: Westchester
• A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
  NCT07276724 · Phase: Phase 3 · Ages: 12 Years to 80 Years · Sex: All (male and female) · Illinois: Glenview
• A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
  NCT06977581 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Illinois: Champaign
• ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
  NCT07301255 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Illinois: Maryville
• Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
  NCT06307665 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · Illinois: Normal, River Forest
• Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
  NCT04278404 · Phase: Not specified · Ages: 0 Years to 20 Years · Sex: All (male and female) · Illinois: Chicago
• Post-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Neonatal Intermittent Hypoxemia in Preterm Infants at Pre-School Age
  NCT05336890 · Phase: Not specified · Ages: 30 Weeks to 83 Months · Sex: All (male and female) · Illinois: Chicago
• Protocol CAUSE-03 / CHEETAH
  NCT06136091 · Phase: Not specified · Ages: 6 Years to 17 Years · Sex: All (male and female) · Illinois: Chicago
• Registry of Asthma Characterization and Recruitment 3 (RACR3)
  NCT05272241 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Illinois: Chicago
• Soy Isoflavones For Inner City Infants At Risk For Asthma (SIRA) Study
  NCT05667701 · Phase: Phase 2 · Ages: 2 Months to 12 Months · Sex: All (male and female) · Illinois: Chicago
• Technology-Enhanced Asthma Care in Children at Clinic and Home Study
  NCT06820593 · Phase: Not applicable (e.g. observational or device study) · Ages: 4 Years and older · Sex: All (male and female) · Illinois: Chicago